PACC1
gene geneOn this page
Also known as FLJ10874PACASORPAORAC
Summary
PACC1 (proton activated chloride channel 1, HGNC:25593) is a protein-coding gene on chromosome 1q32.3, encoding Proton-activated chloride channel (Q9H813). Chloride channel gated by pH that facilitates the entry of chloride ions into cells upon exposure to extracellular acidic pH.
Enables pH-gated chloride channel activity. Involved in chloride transport. Located in plasma membrane.
Source: NCBI Gene 55248 — RefSeq curated summary.
At a glance
- GWAS associations: 6
- Clinical variants (ClinVar): 87 total
- MANE Select transcript:
NM_018252
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:25593 |
| Approved symbol | PACC1 |
| Name | proton activated chloride channel 1 |
| Location | 1q32.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ10874, PAC, ASOR, PAORAC |
| Ensembl gene | ENSG00000065600 |
| Ensembl biotype | protein_coding |
| OMIM | 618427 |
| Entrez | 55248 |
Gene structure
Transcript identifiers
Ensembl transcripts: 16 — 13 protein_coding, 3 protein_coding_CDS_not_defined
ENST00000261455, ENST00000467822, ENST00000471937, ENST00000478166, ENST00000535273, ENST00000890971, ENST00000890972, ENST00000890973, ENST00000890974, ENST00000921366, ENST00000921367, ENST00000921368, ENST00000921369, ENST00000921370, ENST00000921371, ENST00000960795
RefSeq mRNA: 5 — MANE Select: NM_018252
NM_001198862, NM_001377478, NM_001377479, NM_001377480, NM_018252
CCDS: CCDS1504, CCDS55687
Canonical transcript exons
ENST00000261455 — 8 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001010450 | 212375193 | 212375300 |
| ENSE00001162856 | 212363928 | 212365376 |
| ENSE00003570815 | 212379895 | 212380037 |
| ENSE00003580816 | 212386891 | 212387100 |
| ENSE00003590563 | 212385274 | 212385425 |
| ENSE00003605747 | 212410425 | 212410521 |
| ENSE00003656453 | 212377562 | 212377706 |
| ENSE00003658107 | 212414722 | 212414886 |
Expression profiles
Bgee: expression breadth ubiquitous, 240 present calls, max score 95.17.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 12.3655 / max 176.1941, expressed in 1761 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 17377 | 12.3655 | 1761 |
Top tissues by expression
285 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| C1 segment of cervical spinal cord | UBERON:0006469 | 95.17 | gold quality |
| spinal cord | UBERON:0002240 | 94.42 | gold quality |
| inferior vagus X ganglion | UBERON:0005363 | 94.02 | gold quality |
| corpus callosum | UBERON:0002336 | 92.03 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 91.87 | gold quality |
| secondary oocyte | CL:0000655 | 91.86 | gold quality |
| pons | UBERON:0000988 | 91.46 | gold quality |
| subthalamic nucleus | UBERON:0001906 | 90.60 | gold quality |
| medial globus pallidus | UBERON:0002477 | 90.44 | gold quality |
| cortical plate | UBERON:0005343 | 90.30 | gold quality |
| endothelial cell | CL:0000115 | 89.92 | gold quality |
| globus pallidus | UBERON:0001875 | 89.62 | gold quality |
| substantia nigra pars reticulata | UBERON:0001966 | 89.28 | gold quality |
| superior vestibular nucleus | UBERON:0007227 | 87.85 | gold quality |
| ventricular zone | UBERON:0003053 | 87.04 | gold quality |
| ganglionic eminence | UBERON:0004023 | 86.93 | gold quality |
| monocyte | CL:0000576 | 86.64 | gold quality |
| oocyte | CL:0000023 | 86.58 | gold quality |
| mononuclear cell | CL:0000842 | 86.31 | gold quality |
| leukocyte | CL:0000738 | 85.93 | gold quality |
| midbrain | UBERON:0001891 | 84.64 | gold quality |
| substantia nigra pars compacta | UBERON:0001965 | 84.40 | gold quality |
| prefrontal cortex | UBERON:0000451 | 84.38 | gold quality |
| substantia nigra | UBERON:0002038 | 84.30 | gold quality |
| ventral tegmental area | UBERON:0002691 | 84.27 | gold quality |
| lateral globus pallidus | UBERON:0002476 | 83.82 | gold quality |
| dorsal plus ventral thalamus | UBERON:0001897 | 83.62 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 83.54 | gold quality |
| Ammon’s horn | UBERON:0001954 | 83.41 | gold quality |
| granulocyte | CL:0000094 | 82.26 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 3.70 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
39 targeting PACC1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-12136 | 99.98 | 72.81 | 5713 |
| HSA-MIR-520D-5P | 99.98 | 73.34 | 4883 |
| HSA-MIR-524-5P | 99.98 | 73.43 | 4882 |
| HSA-MIR-302C-5P | 99.97 | 72.56 | 3642 |
| HSA-MIR-3065-5P | 99.97 | 71.56 | 3281 |
| HSA-MIR-4666A-3P | 99.96 | 71.71 | 3434 |
| HSA-MIR-3143 | 99.93 | 71.96 | 3104 |
| HSA-MIR-145-5P | 99.92 | 71.13 | 1836 |
| HSA-MIR-5195-3P | 99.92 | 70.92 | 1877 |
| HSA-MIR-10523-5P | 99.91 | 69.22 | 2038 |
| HSA-MIR-7-1-3P | 99.91 | 71.53 | 4384 |
| HSA-MIR-7-2-3P | 99.91 | 71.40 | 4394 |
| HSA-MIR-3140-3P | 99.88 | 68.47 | 2069 |
| HSA-MIR-548AZ-5P | 99.83 | 69.94 | 3230 |
| HSA-MIR-548T-5P | 99.83 | 69.91 | 3220 |
| HSA-MIR-520F-3P | 99.82 | 71.32 | 1216 |
| HSA-MIR-3913-5P | 99.78 | 67.26 | 968 |
| HSA-MIR-4658 | 99.77 | 64.94 | 514 |
| HSA-MIR-6790-5P | 99.77 | 65.24 | 505 |
| HSA-MIR-3659 | 99.70 | 67.97 | 694 |
| HSA-MIR-561-3P | 99.64 | 70.90 | 3647 |
| HSA-MIR-1287-3P | 99.63 | 66.93 | 492 |
| HSA-MIR-325 | 99.58 | 66.55 | 358 |
| HSA-MIR-3609 | 99.52 | 69.89 | 2587 |
| HSA-MIR-548AH-5P | 99.52 | 69.73 | 2626 |
| HSA-MIR-12117 | 99.50 | 67.57 | 868 |
| HSA-MIR-3122 | 99.50 | 66.33 | 821 |
| HSA-MIR-569 | 99.42 | 66.32 | 1009 |
| HSA-MIR-32-3P | 99.36 | 68.20 | 2517 |
| HSA-MIR-92B-5P | 99.36 | 63.29 | 110 |
Literature-anchored findings (GeneRIF, showing 5)
- PAC (TMEM206) was indentified as being essential for the widely observed proton-activated Cl- (PAC) currents (ICl,H). (PMID:31023925)
- PACC1 encodes a new type of chloride channel activated by acid or proton; its wide expression suggests a broad role for this conserved chloride channel in physiological and pathological processes associated with acidic pH. (PMID:31023925)
- Structures and pH-sensing mechanism of the proton-activated chloride channel. (PMID:33149300)
- Physiological Functions of the Volume-Regulated Anion Channel VRAC/LRRC8 and the Proton-Activated Chloride Channel ASOR/TMEM206. (PMID:37468723)
- Functional expression of the proton sensors ASIC1a, TMEM206, and OGR1 together with BKCa channels is associated with cell volume changes and cell death under strongly acidic conditions in DAOY medulloblastoma cells. (PMID:38627262)
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | pacc1 | ENSDARG00000012271 |
| mus_musculus | Pacc1 | ENSMUSG00000026627 |
| rattus_norvegicus | Pacc1 | ENSRNOG00000003915 |
Protein
Protein identifiers
Proton-activated chloride channel — Q9H813 (reviewed: Q9H813)
Alternative names: Acid-sensitive outwardly-rectifying anion channel, Proton-activated outwardly rectifying anion channel, Transmembrane protein 206
All UniProt accessions (1): Q9H813
UniProt curated annotations — full annotation on UniProt →
Function. Chloride channel gated by pH that facilitates the entry of chloride ions into cells upon exposure to extracellular acidic pH. Involved in acidosis-induced cell death by mediating chloride influx and subsequent cell swelling.
Subcellular location. Cell membrane.
Tissue specificity. Widely expressed, with highest expression in brain.
Post-translational modifications. N-glycosylated.
Similarity. Belongs to the proton-activated chloride channel family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q9H813-1 | 1 | yes |
| Q9H813-2 | 2 |
RefSeq proteins (5): NP_001185791, NP_001364407, NP_001364408, NP_001364409, NP_060722* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR029366 | TMEM206 | Family |
Pfam: PF15122
Catalyzed reactions (Rhea), 1 shown:
- chloride(in) = chloride(out) (RHEA:29823)
UniProt features (40 total): strand 14, helix 5, sequence conflict 4, modified residue 4, topological domain 3, glycosylation site 2, transmembrane region 2, turn 2, chain 1, splice variant 1, sequence variant 1, mutagenesis site 1
Structure
Experimental structures (PDB)
11 structures.
| PDB | Method | Resolution (Å) |
|---|---|---|
| 7SQH | ELECTRON MICROSCOPY | 2.5 |
| 7SQG | ELECTRON MICROSCOPY | 2.6 |
| 8FBL | ELECTRON MICROSCOPY | 2.7 |
| 8EQ4 | ELECTRON MICROSCOPY | 2.71 |
| 8ZLL | ELECTRON MICROSCOPY | 2.89 |
| 7SQF | ELECTRON MICROSCOPY | 3.1 |
| 9LHM | ELECTRON MICROSCOPY | 3.43 |
| 7JNA | ELECTRON MICROSCOPY | 3.6 |
| 9LI2 | ELECTRON MICROSCOPY | 3.72 |
| 7JNC | ELECTRON MICROSCOPY | 3.73 |
| 8ZLB | ELECTRON MICROSCOPY | 3.85 |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9H813-F1 | 79.40 | 0.43 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (4): 9, 10, 14, 24
Glycosylation sites (2): 155, 162
Mutagenesis-validated functional residues (1):
| Position | Phenotype |
|---|---|
| 307 | reduced i(-) permeability. |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 129 (showing top):
GSE18804_SPLEEN_MACROPHAGE_VS_COLON_TUMORAL_MACROPHAGE_DN, RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP, GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_UP, GOCC_CELL_SURFACE, GOBP_INORGANIC_ANION_TRANSPORT, PATIL_LIVER_CANCER, GOBP_CHLORIDE_TRANSPORT, MODULE_239, TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_DN, PU1_Q6, ELK1_01, P300_01, DOUGLAS_BMI1_TARGETS_UP, RGAGGAARY_PU1_Q6, IVANOVA_HEMATOPOIESIS_EARLY_PROGENITOR
GO Biological Process (4): chloride transport (GO:0006821), monoatomic ion transport (GO:0006811), monoatomic ion transmembrane transport (GO:0034220), chloride transmembrane transport (GO:1902476)
GO Molecular Function (3): pH-gated chloride channel activity (GO:0061797), chloride channel activity (GO:0005254), protein binding (GO:0005515)
GO Cellular Component (4): plasma membrane (GO:0005886), cell surface (GO:0009986), chloride channel complex (GO:0034707), membrane (GO:0016020)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 2 |
| monoatomic anion transport | 1 |
| inorganic anion transport | 1 |
| transport | 1 |
| monoatomic ion transport | 1 |
| transmembrane transport | 1 |
| chloride transport | 1 |
| monoatomic anion transmembrane transport | 1 |
| chloride channel activity | 1 |
| ligand-gated monoatomic anion channel activity | 1 |
| pH-gated monoatomic ion channel activity | 1 |
| monoatomic anion channel activity | 1 |
| chloride transmembrane transporter activity | 1 |
| binding | 1 |
| membrane | 1 |
| cell periphery | 1 |
| monoatomic ion channel complex | 1 |
Protein interactions and networks
STRING
796 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| PACC1 | TECRL | Q5HYJ1 | 720 |
| PACC1 | ASGR1 | P07306 | 706 |
| PACC1 | DMBT1 | Q9UGM3 | 632 |
| PACC1 | ESCO1 | Q5FWF5 | 607 |
| PACC1 | ESCO2 | Q56NI9 | 606 |
| PACC1 | GOLPH3 | Q9H4A6 | 578 |
| PACC1 | NOMO2 | Q5JPE7 | 570 |
| PACC1 | TMEM97 | Q5BJF2 | 566 |
| PACC1 | AKT1 | P31749 | 561 |
| PACC1 | NOMO3 | P69849 | 544 |
| PACC1 | NOMO1 | P78421 | 528 |
| PACC1 | LGALS4 | P56470 | 506 |
| PACC1 | PRND | Q9UKY0 | 460 |
| PACC1 | FCF1 | Q9Y324 | 447 |
| PACC1 | PDZK1IP1 | Q13113 | 446 |
IntAct
40 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| TMEM147 | PACC1 | psi-mi:“MI:0915”(physical association) | 0.740 |
| TRDN | TMEM223 | psi-mi:“MI:0914”(association) | 0.640 |
| PACC1 | PLLP | psi-mi:“MI:0915”(physical association) | 0.560 |
| PLP2 | PACC1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SEC22A | PACC1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CTXN3 | PACC1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| PBXIP1 | GOLIM4 | psi-mi:“MI:0914”(association) | 0.530 |
| ASIC4 | UPK3BL1 | psi-mi:“MI:0914”(association) | 0.350 |
| PACC1 | DEGS1 | psi-mi:“MI:0914”(association) | 0.350 |
| SHTN1 | psi-mi:“MI:0914”(association) | 0.350 | |
| TMEM223 | psi-mi:“MI:0914”(association) | 0.350 | |
| NPC1 | psi-mi:“MI:0914”(association) | 0.350 | |
| CANX | HLA-A | psi-mi:“MI:0914”(association) | 0.350 |
| HLA-DRA | TMEM223 | psi-mi:“MI:0914”(association) | 0.350 |
| CHRNA4 | TMEM223 | psi-mi:“MI:0914”(association) | 0.350 |
| CHRNB2 | TMEM131L | psi-mi:“MI:0914”(association) | 0.350 |
| NRSN1 | FAM171A2 | psi-mi:“MI:0914”(association) | 0.350 |
| PACC1 | TNPO2 | psi-mi:“MI:0914”(association) | 0.350 |
| PACC1 | ATP1A3 | psi-mi:“MI:0914”(association) | 0.350 |
| BZW2 | GOLIM4 | psi-mi:“MI:0914”(association) | 0.350 |
| NUDT9 | POF1B | psi-mi:“MI:0914”(association) | 0.350 |
| PACC1 | IPO5 | psi-mi:“MI:0914”(association) | 0.350 |
| SCN3B | NBAS | psi-mi:“MI:0914”(association) | 0.350 |
| ZNF843 | PMPCA | psi-mi:“MI:0914”(association) | 0.350 |
| MFSD14A | FAM171A2 | psi-mi:“MI:0914”(association) | 0.350 |
| TMEM147 | PACC1 | psi-mi:“MI:0915”(physical association) | 0.000 |
| CTXN3 | PACC1 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (193): TMEM206 (Affinity Capture-MS), TMEM206 (Affinity Capture-MS), TMEM206 (Affinity Capture-MS), TMEM206 (Affinity Capture-MS), TMEM206 (Affinity Capture-MS), TMEM206 (Affinity Capture-MS), TMEM206 (Affinity Capture-MS), TMEM206 (Affinity Capture-MS), TMEM206 (Affinity Capture-MS), TMEM147 (Affinity Capture-MS), NOP9 (Affinity Capture-MS), DCUN1D5 (Affinity Capture-MS), KNTC1 (Affinity Capture-MS), WDR3 (Affinity Capture-MS), GNPAT (Affinity Capture-MS)
ESM2 similar proteins: A0A0K8RK34, A0A7H0DND3, A8WH72, A8WUV1, C0HKG1, G1CWH5, G5EBL2, G5ECI1, H2KZM6, O36400, O45201, O76411, P03205, P0C6Z5, P13374, P17634, P18475, P18535, P21063, P24872, P26305, P34259, P34292, P34312, P45442, P52881, P86899, Q07FZ2, Q0IHD6, Q10128, Q10952, Q1HVG2, Q20924, Q5FVR3, Q66653, Q6DE06, Q77MP7, Q86NG3, Q8BJ83, Q93118
Diamond homologs: Q0IHD6, Q0V9Z3, Q2KHV2, Q5RDP8, Q66H28, Q7SY31, Q9D771, Q9H813
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
87 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 70 |
| Likely benign | 3 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1640 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 1:212375296:CTTGT:C | acceptor_gain | 1.0000 |
| 1:212379889:GCCCA:G | donor_loss | 1.0000 |
| 1:212379890:CCCA:C | donor_loss | 1.0000 |
| 1:212379891:CCA:C | donor_loss | 1.0000 |
| 1:212379892:CA:C | donor_loss | 1.0000 |
| 1:212379893:ACCT:A | donor_loss | 1.0000 |
| 1:212379894:CCTT:C | donor_loss | 1.0000 |
| 1:212379955:CTA:C | donor_gain | 1.0000 |
| 1:212379955:CTACT:C | donor_gain | 1.0000 |
| 1:212380035:TTT:T | acceptor_gain | 1.0000 |
| 1:212380036:TT:T | acceptor_gain | 1.0000 |
| 1:212380036:TTCTG:T | acceptor_loss | 1.0000 |
| 1:212380037:TC:T | acceptor_loss | 1.0000 |
| 1:212380038:C:CA | acceptor_loss | 1.0000 |
| 1:212380039:T:A | acceptor_loss | 1.0000 |
| 1:212385423:TAC:T | acceptor_gain | 1.0000 |
| 1:212385427:T:A | acceptor_loss | 1.0000 |
| 1:212386914:T:TA | donor_gain | 1.0000 |
| 1:212386955:A:AC | donor_gain | 1.0000 |
| 1:212386956:C:CC | donor_gain | 1.0000 |
| 1:212387098:GGC:G | acceptor_gain | 1.0000 |
| 1:212387099:GC:G | acceptor_gain | 1.0000 |
| 1:212387100:CC:C | acceptor_gain | 1.0000 |
| 1:212387101:C:CC | acceptor_gain | 1.0000 |
| 1:212410421:TCA:T | donor_loss | 1.0000 |
| 1:212410423:A:C | donor_loss | 1.0000 |
| 1:212410424:C:T | donor_loss | 1.0000 |
| 1:212410517:CTCAG:C | acceptor_gain | 1.0000 |
| 1:212410518:TCAG:T | acceptor_gain | 1.0000 |
| 1:212410519:CAG:C | acceptor_gain | 1.0000 |
AlphaMissense
2324 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 1:212375225:A:G | W287R | 0.993 |
| 1:212375225:A:T | W287R | 0.993 |
| 1:212375223:C:A | W287C | 0.989 |
| 1:212375223:C:G | W287C | 0.989 |
| 1:212365287:A:C | S327R | 0.988 |
| 1:212365287:A:T | S327R | 0.988 |
| 1:212365289:T:G | S327R | 0.988 |
| 1:212377571:G:C | F258L | 0.987 |
| 1:212377571:G:T | F258L | 0.987 |
| 1:212377573:A:G | F258L | 0.987 |
| 1:212379973:A:G | F187S | 0.986 |
| 1:212375229:A:C | F285L | 0.985 |
| 1:212375229:A:T | F285L | 0.985 |
| 1:212375231:A:G | F285L | 0.985 |
| 1:212379945:G:C | F196L | 0.985 |
| 1:212379945:G:T | F196L | 0.985 |
| 1:212379947:A:G | F196L | 0.985 |
| 1:212377637:G:C | F236L | 0.984 |
| 1:212377637:G:T | F236L | 0.984 |
| 1:212377639:A:G | F236L | 0.984 |
| 1:212377649:G:C | F232L | 0.984 |
| 1:212377649:G:T | F232L | 0.984 |
| 1:212377651:A:G | F232L | 0.984 |
| 1:212377572:A:G | F258S | 0.982 |
| 1:212365297:G:T | A324D | 0.981 |
| 1:212379921:G:C | F204L | 0.981 |
| 1:212379921:G:T | F204L | 0.981 |
| 1:212379923:A:G | F204L | 0.981 |
| 1:212379972:G:C | F187L | 0.981 |
| 1:212379972:G:T | F187L | 0.981 |
dbSNP variants (sampled 300 via entrez): RS1000023946 (1:212384738 T>C), RS1000120471 (1:212390786 G>T), RS1000257027 (1:212411620 T>C), RS1000305373 (1:212365020 C>T), RS1000377120 (1:212379194 T>C), RS1000389527 (1:212371717 A>G), RS1000408863 (1:212390606 G>A,C), RS1000446425 (1:212403699 G>T), RS1000527922 (1:212373995 C>T), RS1000590991 (1:212408569 C>A,G,T), RS1000682182 (1:212380903 C>G), RS1000748076 (1:212379410 C>T), RS1000841972 (1:212395724 C>T), RS1000887465 (1:212400967 T>C), RS1000893045 (1:212407235 A>G)
Disease associations
OMIM: gene MIM:618427 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
6 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST004618_26 | White blood cell count (basophil) | 2.000000e-14 |
| GCST004631_47 | Basophil percentage of white cells | 8.000000e-15 |
| GCST004634_6 | Basophil percentage of granulocytes | 1.000000e-16 |
| GCST90002379_18 | Basophil count | 3.000000e-09 |
| GCST90002379_19 | Basophil count | 1.000000e-21 |
| GCST90002380_122 | Basophil percentage of white cells | 9.000000e-26 |
EFO canonical traits (3, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0005090 | basophil count |
| EFO:0007992 | basophil percentage of leukocytes |
| EFO:0007995 | basophil percentage of granulocytes |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
43 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| sodium arsenite | affects cotreatment, increases abundance, increases expression | 2 |
| Valproic Acid | affects expression, decreases methylation, increases expression | 2 |
| Cyclosporine | increases expression | 2 |
| Cadmium Chloride | decreases reaction, increases abundance, increases palmitoylation, increases expression | 2 |
| FR900359 | increases phosphorylation | 1 |
| dicrotophos | decreases expression | 1 |
| lead acetate | increases expression | 1 |
| 2,5,2’,5’-tetrachlorobiphenyl | increases expression | 1 |
| arsenite | affects binding, increases reaction | 1 |
| sulforaphane | increases expression | 1 |
| tris(1,3-dichloro-2-propyl)phosphate | increases expression | 1 |
| butyraldehyde | increases expression | 1 |
| 2-bromopalmitate | increases palmitoylation, decreases reaction, increases abundance | 1 |
| manganese chloride | affects cotreatment, increases abundance, increases expression | 1 |
| cupric chloride | increases expression | 1 |
| coumarin | decreases phosphorylation | 1 |
| perfluorooctane sulfonic acid | increases expression | 1 |
| 2-palmitoylglycerol | increases expression | 1 |
| ICG 001 | decreases expression | 1 |
| Resveratrol | affects cotreatment, increases expression | 1 |
| Sunitinib | increases expression | 1 |
| Fulvestrant | increases methylation | 1 |
| Air Pollutants | increases abundance, increases expression | 1 |
| Arsenic | affects cotreatment, increases abundance, increases expression | 1 |
| Cadmium | decreases reaction, increases abundance, increases palmitoylation | 1 |
| Diuron | decreases expression | 1 |
| Doxorubicin | decreases expression | 1 |
| Estradiol | increases expression | 1 |
| Manganese | affects cotreatment, increases abundance, increases expression | 1 |
| Methotrexate | increases expression | 1 |
Cellosaurus cell lines
2 cell lines: 2 transformed cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_D7H6 | Ubigene HEK293T PACC1 KO | Transformed cell line | Female |
| CVCL_D9M4 | Ubigene HEK293 PACC1 KO | Transformed cell line | Female |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.